CD38 and graft versus host disease: CD38bright CD8+ T cells can predict acute graft-versus-host disease [181], phenotypic changes in CD38+ CD4+ T cells can predict the severity of inflammatory bowel disease [182], and CD38 expression in CD4+, CD8+, or CD25+ T cells is significantly higher in SLE patients than in healthy controls [183].